2026 KAMA 51st Annual Scientific Convention - KHIDI USA Joint Session & Promotional Booth (10.17.2026)

• Date: Oct 17, 2026 (Sat)

• Location: InterContinental Boston

• KHIDI USA participated in the 51st Annual Scientific Convention of the Korean American Medical Association (KAMA), held from October 16–18, 2026, at the InterContinental Boston.

• As part of the convention, KHIDI USA hosted a joint session(Oct 17) highlighting the latest advancements and challenges in Artificial Intelligence (AI) in Healthcare, bringing together medical professionals and researchers to explore emerging technologies and their clinical applications.

• Key topics discussed during the session included:

  1) AI Integration in Clinical Practice: Real-world applications of AI in South Korean healthcare, including Yonsei University's development of an on-premise bilingual medical large language model (LLM) integrated with electronic health records (EHRs) to improve clinical documentation efficiency.

  2) Generative AI in Precision Medicine: Innovative applications of generative AI in radiation oncology, including AI-powered medical imaging, prognosis prediction, personalized treatment planning, and post-treatment evaluation.

  3) Physician-Led AI Governance: The importance of physician oversight, clinical validation, patient safety, and regulatory frameworks in ensuring responsible AI adoption in healthcare.

  4) AI in Medical Research and Education: Opportunities and challenges associated with AI in academic publishing, scientific integrity, and medical education, emphasizing the need to balance technological innovation with professional judgment.

• In addition to the session, KHIDI USA operated a promotional booth to introduce its initiatives and support programs aimed at strengthening Korea–U.S. collaboration in the biohealth sector and to engage with healthcare professionals and researchers.

• Through participation, KHIDI USA continued to foster connections within the Korean American medical community and promote opportunities for cross-border collaboration in healthcare innovation.